Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025.
Saved in:
| Title: | Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025. |
|---|---|
| Authors: | Jacobs JW; Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (J.W.J., G.S.B.)., Booth GS; Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (J.W.J., G.S.B.)., Lewis-Newby M; Divisions of Pediatric Cardiac Critical Care and Pediatric Bioethics and Palliative Care, Departments of Pediatrics and Bioethics and Humanities, University of Washington School of Medicine, Seattle Children's Hospital, Seattle; and Treuman Katz Center for Pediatric Bioethics and Palliative Care, Seattle Children's Research Institute, Seattle, Washington (M.L.-N.)., Saifee NH; Department of Laboratory Medicine and Pathology, University of Washington, Seattle; and Department of Laboratory Medicine and Pathology, Seattle Children's Hospital, Seattle, Washington (N.H.S.)., Ferguson E; School of Psychology, The University of Nottingham, Nottinghamshire, United Kingdom; and National Institute for Health and Care Research Blood and Transplant Research Unit in Donor Health and Behaviour, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom (E.F.)., Cohn CS; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota; and Association for the Advancement of Blood and Biotherapies (AABB), Bethesda, Maryland (C.S.C.)., Delaney M; Division of Pathology & Laboratory Medicine, Children's National Hospital, Washington, DC (M.D.)., Morley S; New Zealand Blood Service, Auckland, New Zealand (S.M.)., Thomas S; Joint Professional Advisory Committee, London; and NHS Blood and Transplant, London, United Kingdom (S.T.)., Thorpe R; Research and Development, Australian Red Cross Lifeblood, West Melbourne, Victoria, Australia; and Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia (R.T.)., Raza S; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada (S.R.)., Weaver MS; Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska (M.S.W.)., Woo JS; Department of Pathology, City of Hope National Medical Center, Irvine, California (J.S.W.)., Sharma D; Division of Transfusion Medicine, Department of Pathology, Microbiology & Immunology, and Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee (D.S.)., So-Osman C; Department of Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands; and Department of Haematology, Erasmus Medical Center, Rotterdam, the Netherlands (C.S.-O.)., Yurtsever N; Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut (N.Y., C.A.T.)., Tormey CA; Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut (N.Y., C.A.T.)., Waters A; Irish Blood Transfusion Service, National Blood Centre, Dublin; and UCD School of Public Health, Physiotherapy and Social Science, University College Dublin, Dublin, Ireland (A.W.)., Goldman M; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa; and Medical Affairs and Innovation, Canadian Blood Services, Ottawa, Ontario, Canada (M.G.)., Yan MTS; Medical Affairs and Innovation, Canadian Blood Services, Ottawa, Ontario, Canada (M.T.S.Y.)., Fasano RM; Center for Transfusion and Cellular Therapy, Department of Pathology and Laboratory Medicine, Emory University, Atlanta; and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia (R.M.F.)., Stephens LD; Department of Pathology, University of California San Diego, La Jolla, California (L.D.S., E.S.A.)., Allen ES; Department of Pathology, University of California San Diego, La Jolla, California (L.D.S., E.S.A.)., Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus; and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (C.E.)., Infanti L; Regional Transfusion Centre Swiss Red Cross Basel, Basel; and Division of Hematology, University Hospital of Basel, Basel, Switzerland (L.I.)., Schlafer TD; Lincoln Memorial University Duncan School of Law, Knoxville, Tennessee (T.D.S.)., Warner MA; Department of Anesthesiology and Perioperative Medicine, and Patient Blood Management Program, Mayo Clinic, Rochester, Minnesota (M.A.W.)., Winters JL; Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (J.L.W.)., Tobian AAR; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (A.A.R.T., E.M.B.)., Bloch EM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (A.A.R.T., E.M.B.). |
| Source: | Annals of internal medicine [Ann Intern Med] 2025 Jul; Vol. 178 (7), pp. 1021-1026. Date of Electronic Publication: 2025 May 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1539-3704 |
|---|---|
| DOI: | 10.7326/ANNALS-25-00815 |
